Sparta Biomedical
Madison, US · Founded 2019 · Wyoming corporation · 1 known investors
Sparta Biomedical develops chemically engineered cartilage implants built on its Hyalos hydrogel platform, including Karthyx, an MTP hemiarthroplasty device that combines the cartilage-mimicking hydrogel with a titanium fixation technology. The company targets treatment of joint cartilage degeneration and osteoarthritis through cartilage-like implants for joints such as the great toe.
Founders & leadership
KG
Ken GallDirector
DS
Dushyanth SurakantiExecutive Officer, Director
DA
Dimitrios AngelisExecutive Officer, Director
SF
Sean FontenotDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$5.3MraisedJan 2022 · 53 investors · Other Health CareRule 506(b)
▶$5.3MraisedJan 2022 · 53 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ken GallDirector
- Dushyanth SurakantiExecutive Officer, Director
- Dimitrios AngelisExecutive Officer, Director
- Sean FontenotDirector
- Offering amount
- $5.4M
- Amount sold
- $5.3M
- First sale
- Dec 2021
- Incorporated
- Corporation, Wyoming, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.